TARGETED THERAPY

We are providing cost-effective solutions for different targeted therapies in oncology. In Pakistan, the Drug Regulatory Authority has allowed the import of the not available / not registered products on a patient name basis. We have been working on all those targeted therapies which are not available in Pakistan and are importing them as per the Patient’s need.

Immunotherapies Biosimilars
Regorafenib Adalimumab
Lenvatinib Peg-Filgrastim
Ibrutinib Denosumab
Crizotinib Ranibizumab
Osimertinib Nivolumab
Peg-Doxorubicin Pertuzumab
Pralatrexate Ranibizumab
Tofacitinib Natalizumab
Trametinib Abciximab
Treosulfan Trastuzumab
Thiotepa Ustekinumab
Olaparib Canakinumab
Perfenidone
Dabrafenib
Erlotinib
Nilotinib
Lapatinib
TOP